SHALDON MEDICO-LEGAL LIMITED

Company Registration Number:
11146454 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

SHALDON MEDICO-LEGAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

SHALDON MEDICO-LEGAL LIMITED

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 51,135 66,707
Investments: 4 200,000 0
Total fixed assets: 251,135 66,707
Current assets
Stocks: 0 0
Debtors: 5 636,945 657,929
Cash at bank and in hand: 262,937 561,381
Investments:   0 0
Total current assets: 899,882 1,219,310
Creditors: amounts falling due within one year:   (128,410) (143,826)
Net current assets (liabilities): 771,472 1,075,484
Total assets less current liabilities: 1,022,607 1,142,191
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: (12,784) (12,056)
Total net assets (liabilities): 1,009,823 1,130,135
Capital and reserves
Called up share capital: 160 160
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 1,009,663 1,129,975
Shareholders funds: 1,009,823 1,130,135

The notes form part of these financial statements

SHALDON MEDICO-LEGAL LIMITED

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 December 2024
and signed on behalf of the board by:

Name: Vidas Cooling
Status: Director

The notes form part of these financial statements

SHALDON MEDICO-LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances

Tangible fixed assets and depreciation policy

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases: Plant and Machinery 25 per cent Reducing Balance Motor Vehicles 25 per cent Reducing Balance Computer Equipment 25 per cent Reducing Balance

Other accounting policies

Taxation Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively. Investments Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

SHALDON MEDICO-LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 4 5

SHALDON MEDICO-LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Tangible Assets

Total
Cost £
At 01 April 2023 90,966
Additions 1,474
Disposals 0
Revaluations 0
Transfers 0
At 31 March 2024 92,440
Depreciation
At 01 April 2023 24,259
Charge for year 17,046
On disposals 0
Other adjustments 0
At 31 March 2024 41,305
Net book value
At 31 March 2024 51,135
At 31 March 2023 66,707

SHALDON MEDICO-LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Fixed investments

Investments Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

SHALDON MEDICO-LEGAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Debtors

2024 2023
££
Debtors due after more than one year: 408,286 402,862